ICYMI: WSJ and NYT highlight concerns with Part B International Pricing Index Model

Medicare Part B is a market-based system that has enabled millions of seniors and patients with disabilities to access needed medicines. Reimbursement for medicines in Part B is based on the Average...
Read More
New study finds hospitals prescribe more medicines, and more expensive medicines, after joining 340B program

Data and analyses continue to show the 340B program influences prescribing trends at 340B hospitals – ultimately costing patients and our health care system more money. The Government Accountability...
Read More
Ask About Adherence: Poor medication adherence leads to negative health outcomes and increased health care costs

Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we are pleased to share a blog post from Xue Han.
Read More
New research shows increasing medication-assisted treatment rates could prevent 6.1 million overdoses and save over 800,000 lives

New research released this week highlights the barriers that patients face in accessing medication-assisted treatment (MAT) for opioid use disorder (OUD) and the personal, health and societal...
Read More
Six key facts about the market for insulins

The insulin market is commonly mischaracterized as lacking competition. In fact, robust competition among biopharmaceutical companies that produce insulin results in increasing levels of discounts...
Read More
New report shows nearly 300 cell and gene therapies in development

Fifty years ago, the idea of altering a gene to treat or even cure a disease was considered science fiction. Today, cell and gene therapy are transforming treatment options for some patients and are...
Read More
World AIDS Day 2018: Hope for the future

Each year, I write to commemorate World AIDS Day which is now in its 30th year spotlighting patients living with HIV and those we’ve sadly lost to AIDS-related illnesses.
Read More